Patient Education Library |
Staff Information : Amanda C. Wilks MMSc, PA-C
Amanda C. Wilks MMSc, PA-C
Biographic:Born: September 18, 1976 Education:Emory University School of Medicine Program Description: Medical Mission Trip Georgia Southwestern State University Hometown: Montezuma, Georgia PROFESSIONAL EXPERIENCE:Dermatology Associates of Knoxville, PC Pediatric and Adolescent Medicine(1/14/02-7/31/03) Pediatric and Adolescent Medicine(9/03-11/03) Americus GYN-OB(Fall 1996-Summer 1999) PROFESSIONAL CERTIFICATIONS:Pediatric Acute Life Support (4/02-4/04) Advanced Cardiac Life Support (6/02-6/04) Basic Life Support Certification (6/02-6/04) PROFESSIONAL ASSOCIATIONS:American Academy of Physician Assistants RESEARCH EXPERIENCE:A Multicenter, Randomized, Double Blind, Vehicle Controlled Study of the Safety and Efficacy of a topical foam in the treatment of mild to severe Atopic Dermatitis. A double-blind, randomized, parallel-group, Placebo controlled, Multi-center study to compare the clinical equivalence of a topical gel Generic formula, in subjects with moderate to severe Acne Rosacea. A randomized, double-blind, placebo controlled, Phase III study of an extended release oral medication for the treatment of inflammatory lesions of Acne Vulgaris. A Randomized, Double Blind, Parallel Group, Multicenter, Phase 3 Extension, Efficacy and Safety Study of Nail Lacquer or Placebo Combined with Oral Lamisil in the Treatment of Onychomycosis. An Open Label, Single Group, Multicenter, Phase 3 Extension Study to Assess the Maintenance use of a Nail Lacquer in the Treatment of Onychomycosis. A Phase IV, Multicenter, Open-Label Randomized study of the Safety and Efficacy of Low-Dose oral medication for the treatment of Moderate to Severe Plaque-Type Psoriasis. A 5 Year Assessment and Tracking of a Long-term Safety Study with a FDA approved IM Injection in Subjects with Moderate to Severe Chronic Plaque Psoriasis. A 10 Year Prospective Pediatric Evaluation to Assess the Long-Term Safety of an Ointment for the Treatment of Atopic Dermatitis. A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of a Study Foam versus an FDA approved Cream in the Treatment of Seborrheic Dermatitis. A Phase 4, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Cross-Over Study to Further Evaluate the Risk of Hematological Adverse Events in G6PD-Deficient Subjects with Acne Vulgaris treated with a Gel. A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Two Shampoos in Patients with Tinea (Pityriasis) Versicolor. A Multi-Center, Double-Blind Clinical Comparison of the Efficacy and Safety of a Topical Gel and Vehicle Gel in the Once Daily Treatment of Acne Vulgaris for 12 Weeks. A Randomized, Double-blind, Parallel-group, Vehicle-Controlled, Multicenter Study to Determine the Safety and Theraputic Equivalence of a Generic Formulation of Cream compared to FDA Approved Cream in the Treatment of Actinic Keratosis. |





